Dawei Xuan
Impact in
- Molecular Medicine top 2%
- Antibiotic Resistance in Bacteria
- Pharmacology top 5%
- Antibiotics Pharmacokinetics and Efficacy
Papers in
- Pharmacology 14
- Antibiotics Pharmacokinetics and Efficacy 14
- Oncology 11
- HER2/EGFR in Cancer Research 8
- Cancer Treatment and Pharmacology 4
- Colorectal Cancer Treatments and Studies 3
- Co-authors
- David P. Nicolau (16 shared papers)Charles H. Nightingale (15 shared papers)Ronald Shazer (3 shared papers)Joanna C. Masters (1 shared paper)Dana J. Nickens (1 shared paper)Michael Amantea (1 shared paper)Richard Quintiliani (8 shared papers)Pamela R. Tessier (5 shared papers)
- Journals
- Antimicrobial Agents and Chemotherapy (7 papers)Journal of Clinical Oncology (4 papers)International Journal of Antimicrobial Agents (3 papers)Investigational New Drugs (2 papers)Chemotherapy (2 papers)
- Partner nations
- United StatesSpainUnited Kingdom
In The Last Decade
Dawei Xuan
35 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 99
- Molecular Medicine 179
- Pharmacology 316
- Applied Microbiology and Biotechnology 29
- Oncology 349
- Radiology, Nuclear Medicine and Imaging 218
Countries citing papers authored by Dawei Xuan
This map shows the geographic impact of Dawei Xuan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dawei Xuan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dawei Xuan more than expected).
Fields of papers citing papers by Dawei Xuan
This network shows the impact of papers produced by Dawei Xuan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dawei Xuan. The network helps show where Dawei Xuan may publish in the future.
Co-authors
The 25 scholars most cited alongside Dawei Xuan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 235 | |
| 2 | 1996 | 156 | |
| 3 | 2021 | 69 | |
| 4 | 2002 | 62 | |
| 5 | 2004 | 42 | |
| 6 | 2019 | 42 | |
| 7 | 2020 | 40 | |
| 8 | 2002 | 38 | |
| 9 | 2002 | 38 | |
| 10 | 2017 | 37 | |
| 11 | 2016 | 37 | |
| 12 | 2001 | 36 | |
| 13 | 2002 | 30 | |
| 14 | 2009 | 26 | |
| 15 | 2018 | 22 | |
| 16 | 2001 | 21 | |
| 17 | 2002 | 18 | |
| 18 | 2000 | 17 | |
| 19 | 2016 | 15 | |
| 20 | 2003 | 13 |
About Dawei Xuan
Dawei Xuan is a scholar working on Pharmacology, Oncology, Epidemiology, Molecular Medicine and Molecular Biology, having authored 35 papers that have together received 1.1k indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (14 papers), Antibiotic Resistance in Bacteria (11 papers), Pneumonia and Respiratory Infections (10 papers), HER2/EGFR in Cancer Research (8 papers), Cancer Treatment and Pharmacology (4 papers), Monoclonal and Polyclonal Antibodies Research (3 papers), Colorectal Cancer Treatments and Studies (3 papers) and Analytical Methods in Pharmaceuticals (3 papers). The work is most often cited by research in Molecular Medicine (179 citations), Pharmacology (316 citations), Applied Microbiology and Biotechnology (29 citations), Oncology (349 citations) and Radiology, Nuclear Medicine and Imaging (218 citations). Dawei Xuan has collaborated with scholars based in United States, Spain and United Kingdom. Frequent co-authors include David P. Nicolau, Charles H. Nightingale, Ronald Shazer, Joanna C. Masters, Dana J. Nickens, Michael Amantea, Richard Quintiliani, Pamela R. Tessier, C H Nightingale and Myo‐Kyoung Kim. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Journal of Clinical Oncology, International Journal of Antimicrobial Agents, Investigational New Drugs and Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.